| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 13.108 | 28.447 | 27.576 | 29.312 | 28.663 | 27.950 | 35.906 |
| Total Income - EUR | - | - | - | 13.138 | 28.461 | 28.051 | 46.899 | 33.812 | 34.226 | 65.132 |
| Total Expenses - EUR | - | - | - | 17.628 | 34.464 | 32.092 | 31.299 | 31.790 | 29.917 | 61.139 |
| Gross Profit/Loss - EUR | - | - | - | -4.491 | -6.003 | -4.041 | 15.599 | 2.023 | 4.309 | 3.993 |
| Net Profit/Loss - EUR | - | - | - | -4.887 | -6.562 | -4.299 | 15.330 | 1.735 | 4.018 | 2.122 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Clariss Optiq Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 459 | 6.717 | 5.025 | 3.542 | 2.178 | 800 | 35 |
| Current Assets | - | - | - | 11.214 | 17.788 | 25.941 | 32.295 | 34.734 | 42.091 | 17.196 |
| Inventories | - | - | - | 9.481 | 15.177 | 23.079 | 29.410 | 31.721 | 34.783 | 14.568 |
| Receivables | - | - | - | 1.363 | 1.365 | 1.339 | 1.354 | 1.415 | 1.411 | 1.403 |
| Cash | - | - | - | 369 | 1.245 | 1.523 | 1.531 | 1.598 | 5.897 | 1.224 |
| Shareholders Funds | - | - | - | -4.949 | -11.415 | -15.498 | 176 | 1.912 | 5.924 | 8.012 |
| Social Capital | - | - | - | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | - | - | - | 16.623 | 35.920 | 46.464 | 35.661 | 35.000 | 36.968 | 9.218 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Clariss Optiq Med S.r.l.